L., Peters, A., & Wagenknecht, L
In this study, there was no increase in HbA 1c or hypoglycemic events reported with increasing semaglutide doses, which provides further evidence of the safety of semaglutide even at higher doses
Follow-up visit : During the IV/IM therapy plan, a follow-up visit is arranged with the healthcare Prescriber to assess progress on the treatment/ therapy plan, make any necessary adjustments if necessary, and provide ongoing support and guidance
doi: 10.14202/vetworld.2025.808-818 43 HoppenbrouwersT.Cveji HogervorstJ
The manufacturers develop their products through advanced formulas, which they monitor with strict quality control measures while meeting WHO-GMP and FSSAI certification requirements